StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) stock

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$332.16−3.36 (-1.00%)

Close on Nov 17, 2026Market cap $15.86BP/E –Yield –

How the market prices Charles River Laboratories International

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Charles River Laboratories International trades at 403× its earnings, against a median of 29.8× since 2016 — dearer than 96% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to earnings since 2016

Median 29.8×, today 403×

What Charles River Laboratories International keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Operating margin2.25%vs 0.72%
EBITDA margin9.70%vs 3.48%
Net margin-5.96%vs 0.67%
Free cash flow margin9.27%vs 5.32%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity-7.70%vs 2.51%
Return on assets-3.16%vs -2.60%
Return on invested capital1.32%vs 4.91%
Return on capital employed1.41%vs 3.07%

How hard the assets work

Revenue per dollar of assets0.53vs 0.84
Revenue per employee$202.99Kvs $216.79K
Profit per employee-$12.10Kvs -$799

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Borrowings exceed cash by $2.43B, or 6.3 times a year of EBITDA. That is 13.3% of the $18.30B it would cost to buy the business outright.

Total debt$2.63B
Cash and short-term investments$192.03M
EBITDA, trailing twelve months$388.03M
Free cash flow, trailing twelve months$370.61M

Leverage and liquidity

Debt to equity0.92vs 0.46
Debt to EBITDA6.77vs 2.59
Net debt to EBITDA6.27vs 2.05
Debt to free cash flow7.08vs 3.72
Current ratio1.35vs 1.35
Quick ratio0.80vs 0.73

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

2.94
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

4 of 9 tests passed

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield-1.50%vs 0.84%
Free cash flow yield2.34%vs 3.72%
Buyback yield2.04%vs 2.02%
Shareholder yield2.04%vs 2.04%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$146.1952-week low52-week high$379.63
200-day50-day$332.1620-day

The close sits 80% of the way up the 52-week range, 12.5% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

50
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

CRLS&P 500
PeriodCRLS&P 500DifferenceCRL per yearS&P 500 per year
1 month+10.7%-4.0%+14.7 pts
3 months+15.9%-5.0%+20.9 pts
Year to date+66.5%+8.2%+58.3 pts
1 year+104.1%+11.2%+92.9 pts
3 years+75.7%+68.5%+7.2 pts+20.7%+19.0%
5 years-15.5%+67.3%−82.8 pts-3.3%+10.8%
10 years+350.6%+291.6%+59.0 pts+16.2%+14.6%

How much it moves

Volatility, 1 year47.6%vs 62.7%
Volume against its 90-day average0.69vs 0.74

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M CRL shares were sold short on Oct 30, 2026, up 5.4% from the previous report, or 6.33% of the shares available to trade. At recent volumes it would take 2.2 days to buy them back. Over the last 20 sessions, 52.8% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float6.33%vs 5.23%
Short interest as a share of all shares6.26%vs 3.52%
Days of volume to buy it back2.23vs 4.25

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20262,987,094+5.4%1,337,3132.2
Oct 15, 20262,834,023-1.5%978,5302.9
Sep 30, 20262,878,537+29.1%1,071,0702.7
Sep 15, 20262,230,517-12.0%811,6912.8
Aug 31, 20262,535,053+7.4%913,0072.8
Aug 14, 20262,360,745-31.0%1,063,4482.2
Jul 31, 20263,419,974+2.3%841,7924.1
Jul 15, 20263,343,526-23.2%837,2324.0
Jun 30, 20264,354,792+20.5%1,023,0684.3
Jun 15, 20263,612,693-7.3%690,3015.2
May 29, 20263,897,904+7.3%1,077,2743.6
May 15, 20263,632,420+8.5%948,9673.8

Every measure, in full

90 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Jan 12, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Jun 27, 2026
Share price as of
Nov 17, 2026

Valuation ratiosIndustry

Market Cap
$15.86B
$298.20M
Enterprise Value
$18.30B
$313.63M
PS Ratio
3.97
1.80
PB Ratio
5.58
2.87
P/FCF Ratio
42.79
17.69
P/OCF Ratio
27.24
14.78

Enterprise valuationIndustry

EV / Sales
4.58
1.77
EV / EBITDA
47.15
15.84
EV / EBIT
202.97
21.61
EV / FCF
49.37
21.12

Share statisticsIndustry

Shares Change (YoY)
-3.97%
1.10%
Shares Change (QoQ)
-0.91%
0.00%
Float
47M
27M
Shares Held by Insiders
1.15%
4.85%
Shares Held by Institutions
119.1%
67.7%

Short sellingIndustry

Short Interest
3M
–
Short Interest Change
5.40%
-4.59%
Short % of Float
6.33%
5.23%
Short % of Shares Outstanding
6.26%
3.52%
Days to Cover
2.23
4.25

Stock price statisticsIndustry

52-Week High
$379.63
–
52-Week Low
$146.19
–
20-Day Moving Average
$345.55
–
50-Day Moving Average
$313.03
–
200-Day Moving Average
$228.93
–
Average True Range (14)
$15.54
–
Price Change (1 Week)
-3.94%
-3.48%
Price Change (1 Month)
10.7%
-4.12%
Price Change (3 Months)
14.5%
-12.7%
Price Change (6 Months)
117.9%
4.74%
Price Change (YTD)
66.5%
-4.12%
Price Change (1 Year)
97.9%
-4.79%
Price Change (3 Years)
75.7%
-26.2%
Price Change (5 Years)
-14.3%
-38.9%
Price Change (10 Years)
351.9%
77.7%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
1M
–
Average Volume (90 Days)
1M
–
Relative Volume
0.69
0.74
Relative Strength Index (14)
50.0
44.7
Volatility (1 Year)
47.6%
62.7%

MarginsIndustry

Profit Margin
-5.96%
0.67%
EBITDA Margin
9.70%
3.48%
FCF Margin
9.27%
5.32%

Returns on capitalIndustry

Return on Equity (ROE)
-7.70%
2.51%
Return on Assets (ROA)
-3.16%
-2.60%
Return on Invested Capital (ROIC)
1.32%
4.91%
Return on Capital Employed (ROCE)
1.41%
3.07%

Financial positionIndustry

Current Ratio
1.35
1.35
Quick Ratio
0.80
0.73
Debt / Equity
0.92
0.46
Debt / EBITDA
6.77
2.59
Debt / FCF
7.08
3.72
Net Debt / EBITDA
6.27
2.05
Interest Coverage
0.85
-0.19

GrowthIndustry

Revenue Growth (YoY)
-0.74%
4.22%
FCF Growth (YoY)
-35.9%
-11.9%
Revenue Growth (3Y CAGR)
0.33%
5.14%
Revenue Growth (5Y CAGR)
6.55%
7.65%

EfficiencyIndustry

Asset Turnover
0.53
0.84
Revenue Per Employee
$202.99K
$216.79K
Profits Per Employee
-$12.10K
-$799
Employee Count
19,700
99

Income statement (TTM)Industry

Revenue
$4.00B
$23.60M
Operating Income
$90.14M
-$48.83K
Net Income
-$238.46M
-$62.45K
EBITDA
$388.03M
-$25.17K
EPS (Diluted)
-$4.91
$0.00

Balance sheetIndustry

Total Debt
$2.63B
$90.03M
Net Cash (Debt)
-$2.43B
$15.49K
Net Cash Per Share
-$50.97
$0.00
Equity (Book Value)
$2.84B
$12.47M
Book Value Per Share
$59.48
$0.69
Tangible Book Value
-$490.39M
$7.70K
Working Capital
$394.36M
$3.69M

Cash flow (TTM)Industry

Operating Cash Flow
$582.15M
$41.37K
Capital Expenditures
-$211.54M
-$8.00M
Free Cash Flow
$370.61M
$10.83M
FCF Per Share
$7.76
$0.60

Dividends and yieldsIndustry

Earnings Yield
-1.50%
0.84%
FCF Yield
2.34%
3.72%
Buyback Yield
2.04%
2.02%
Shareholder Yield
2.04%
2.04%

Taxes and interestIndustry

Interest Expense
$106.26M
$590.77K
Income Tax
$52.63M
$1.35M

Scores and fair valueIndustry

Altman Z-Score
2.94
2.92
Piotroski F-Score
4
5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?